For cellular entry, coxsackievirus binds to molecules such as DAF and ICAM-1, which are frequently overexpressed in certain cancers—like melanoma, multiple myeloma, and breast cancer [67] While antibody neutralization remains a barrier for coxsackieviruses, serotypic differences make cross-reactivity rare. This evidence concerns the gene CD55 and cancer.